| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Research Officer
1 company
Grigoriadis Dimitri E. is a Chief Research Officer at NEUROCRINE BIOSCIENCES INC. Recent SEC Form 4 filings include 0 buys and 10 sells.
Estimated insider holdings value: $14.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jan 16, 2018 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 1,625 | $79.12 | $128,563.01 | -2.0% | |
| Nov 8, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 30,000 | $74.58 | $2,237,343.00 | -27.9% | |
| Aug 9, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sale+OE | 15,354 | $55.00 | $844,470.00 | -12.5% | |
| May 23, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 10,000 | $53.39 | $533,900.00 | -8.5% | |
| May 2, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 10,000 | $55.00 | $550,000.00 | -7.8% | |
| Apr 12, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 13,065 | $50.42 | $658,773.93 | -4.9% | |
| Feb 6, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 727 | $43.13 | $31,355.51 | -0.6% | |
| Feb 3, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 1,375 | $42.56 | $58,520.00 | -1.2% | |
| Jan 17, 2017 | NBIX Neurocrine Biosciences Inc | Chief Research Officer | Sell | 1,625 | $40.63 | $66,023.75 | -1.4% |